BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Staging
22 results:

  • 1. Diagnostic value of [ 68 Ga]Ga-Pentixafor PET/CT in malignant melanoma: a pilot study.
    Manafi-Farid R; Mahini M; Mirshahvalad SA; Fallahi B; Fard-Esfahani A; Emami-Ardekani A; Eftekhari M; Mousavi SA; Beiki D
    Nucl Med Commun; 2024 Mar; 45(3):221-228. PubMed ID: 38214076
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
    Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
    Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prognostic Value of Whole-Body PET Volumetric Parameters Extracted from
    Thuillier P; Liberini V; Grimaldi S; Rampado O; Gallio E; Santi B; Arvat E; Piovesan A; Filippi R; Abgral R; Molinari F; Deandreis D
    J Nucl Med; 2022 Jul; 63(7):1014-1020. PubMed ID: 34740949
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Sporadic Primary Pheochromocytoma: A Prospective Intraindividual Comparison of Six Imaging Tests (CT, MRI, and PET/CT Using
    Jha A; Patel M; Carrasquillo JA; Ling A; Millo C; Saboury B; Chen CC; Wakim P; Gonzales MK; Meuter L; Knue M; Talvacchio S; Herscovitch P; Rivero JD; Chen AP; Nilubol N; Taïeb D; Lin FI; Civelek AC; Pacak K
    AJR Am J Roentgenol; 2022 Feb; 218(2):342-350. PubMed ID: 34431366
    [No Abstract]    [Full Text] [Related]  

  • 5. Correlation of 68Ga-DOTATATE uptake on PET/CT with pathologic features of cellular proliferation in neuroendocrine neoplasms.
    Karls S; Gold R; Kravets S; Wang Y; Cheng S; Perez K; Chan J; Jacene H
    Ann Nucl Med; 2021 Sep; 35(9):1066-1077. PubMed ID: 34146243
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Diagnostic value of [
    Jamsek J; Hocevar M; Bergant D; Zaletel K; Rep S; Lezaic L
    Ann Nucl Med; 2021 Apr; 35(4):429-437. PubMed ID: 33544320
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. First Experience Using
    Kessler L; Schlitter AM; Krönke M; von Werder A; Tauber R; Maurer T; Robinson S; Orlandi C; Herz M; Yousefi BH; Nekolla SG; Schwaiger M; Eiber M; Rischpler C
    J Nucl Med; 2021 Apr; 62(4):479-485. PubMed ID: 32859709
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The association between active tumor volume, total lesion glycolysis and levels of S-100B and LDH in stage IV melanoma patients.
    Deckers EA; Kruijff S; Brouwers AH; van der Steen K; Hoekstra HJ; Thompson JF; Vállez García D; Wevers KP
    Eur J Surg Oncol; 2020 Nov; 46(11):2147-2153. PubMed ID: 32819759
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Volumetric 68Ga-DOTA-TATE PET/CT for assessment of whole-body tumor burden as a quantitative imaging biomarker in patients with metastatic gastroenteropancreatic neuroendocrine tumors.
    Ohlendorf F; Henkenberens C; Brunkhorst T; Ross TL; Christiansen H; Bengel FM; Derlin T
    Q J Nucl Med Mol Imaging; 2022 Dec; 66(4):361-371. PubMed ID: 32286768
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Gastric schwannoma with giant ulcer and lymphadenopathy mimicking gastric cancer: a case report.
    Tang C; Pan Q; Xu Z; Zhou X; Wang Y
    BMC Gastroenterol; 2020 Feb; 20(1):36. PubMed ID: 32059647
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. 18F-Flourodeoxy glucose PET-computed tomography in testicular carcinoma: diagnostic and prognostic value.
    Soydal C; Araz M; Urun Y; Gulpinar B; Nak D; Ozkan E; Kucuk NO
    Nucl Med Commun; 2019 Dec; 40(12):1268-1274. PubMed ID: 31568190
    [TBL] [Abstract] [Full Text] [Related]  

  • 12.
    Şimşek DH; Şanlı Y; Kuyumcu S; Başaran B; Mudun A
    Ann Nucl Med; 2018 May; 32(4):297-301. PubMed ID: 29468487
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The primitive extratesticular seminoma: diagnosis of a rare pathology.
    Saba L
    Acta Biomed; 2017 Apr; 88(1):82-85. PubMed ID: 28467339
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. 68Ga-DOTATATE PET/CT Interobserver Agreement for Neuroendocrine tumor Assessment: Results of a Prospective Study on 50 Patients.
    Fendler WP; Barrio M; Spick C; Allen-Auerbach M; Ambrosini V; Benz M; Bluemel C; Grewal RK; Lapa C; Miederer M; Nicolas G; Schuster T; Czernin J; Herrmann K
    J Nucl Med; 2017 Feb; 58(2):307-311. PubMed ID: 27539839
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Diagnostic FDG and FDOPA positron emission tomography scans distinguish the genomic type and treatment outcome of neuroblastoma.
    Liu YL; Lu MY; Chang HH; Lu CC; Lin DT; Jou ST; Yang YL; Lee YL; Huang SF; Jeng YM; Lee H; Miser JS; Lin KH; Liao YF; Hsu WM; Tzen KY
    Oncotarget; 2016 Apr; 7(14):18774-86. PubMed ID: 26959748
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [¹⁸F]fluorodeoxyglucose positron emission tomography/computed tomography and trophoblastic disease: the gynecologist perspective.
    Mangili G; Bergamini A; Giorgione V; Picchio M; Petrone M; Mapelli P; Rabaiotti E; Incerti E; Candiani M
    Q J Nucl Med Mol Imaging; 2016 Jun; 60(2):103-16. PubMed ID: 26868372
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Somatostatin receptor PET in neuroendocrine tumours: 68Ga-DOTA0,Tyr3-octreotide versus 68Ga-DOTA0-lanreotide.
    Putzer D; Kroiss A; Waitz D; Gabriel M; Traub-Weidinger T; Uprimny C; von Guggenberg E; Decristoforo C; Warwitz B; Widmann G; Virgolini IJ
    Eur J Nucl Med Mol Imaging; 2013 Feb; 40(3):364-72. PubMed ID: 23151915
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Predictive value of 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography/computed tomography for outcome of carbon ion radiotherapy in patients with head and neck mucosal malignant melanoma.
    Inubushi M; Saga T; Koizumi M; Takagi R; Hasegawa A; Koto M; Wakatuki M; Morikawa T; Yoshikawa K; Tanimoto K; Fukumura T; Yamada S; Kamada T
    Ann Nucl Med; 2013 Jan; 27(1):1-10. PubMed ID: 22914968
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Focal uptake of 68Ga-DOTATOC in the pancreas: pathological or physiological correlate in patients with neuroendocrine tumours?
    Al-Ibraheem A; Bundschuh RA; Notni J; Buck A; Winter A; Wester HJ; Schwaiger M; Scheidhauer K
    Eur J Nucl Med Mol Imaging; 2011 Nov; 38(11):2005-13. PubMed ID: 21792572
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Malignant transformation to schwannoma in a patient affected by type 1 neurofibromatosis as demonstrated by F-18-FDG-PET/CT.
    Bertagna F; Bosio G; Biasiotto G; Fisogni S; Bercich L; Giubbini R
    Nucl Med Rev Cent East Eur; 2010; 13(1):15-7. PubMed ID: 21154311
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.